These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39126260)

  • 1. Changes in endoscopic activity and classification of lesions with panenteric capsule endoscopy in patients treated for Crohn's disease - a prospective blinded comparison with ileocolonoscopy, faecal calprotectin and C-reactive protein.
    Brodersen JB; Kjeldsen J; Juel MA; Knudsen T; Rafaelsen SR; Jensen MD
    J Crohns Colitis; 2024 Aug; ():. PubMed ID: 39126260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic severity and classification of lesions with pan-enteric capsule endoscopy and ileocolonoscopy in ileocolonic Crohn's disease.
    Brodersen JB; Kjeldsen J; Knudsen T; Jensen MD
    Endosc Int Open; 2023 Jan; 11(1):E32-E38. PubMed ID: 36618875
    [No Abstract]   [Full Text] [Related]  

  • 3. Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn's disease: A European multicentre observational cohort study.
    Tai FWD; Ellul P; Elosua A; Fernandez-Urien I; Tontini GE; Elli L; Eliakim R; Kopylov U; Koo S; Parker C; Panter S; Sidhu R; McAlindon M
    United European Gastroenterol J; 2021 Mar; 9(2):248-255. PubMed ID: 32741315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohn's disease: a multicentre, prospective study.
    Bruining DH; Oliva S; Fleisher MR; Fischer M; Fletcher JG;
    BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32499275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn's Disease.
    Oliva S; Aloi M; Viola F; Mallardo S; Civitelli F; Maccioni F; Hassan C; Papoff P; Cucchiara S; Cohen SA
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2060-2067.e1. PubMed ID: 30326301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of capsule endoscopy in the phenotype of Crohn's disease. Data from England 2016-2021.
    Oka P; Vibhishanan S; Chetcuti Zammit S; Sidhu R
    Arab J Gastroenterol; 2024 Aug; 25(3):288-292. PubMed ID: 39048386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon Capsule Endoscopy in the Assessment of Mucosal Healing in Crohn's Disease.
    Papalia I; Tjandra D; Quah S; Tan C; Gorelik A; Sivanesan S; Macrae F
    Inflamm Bowel Dis; 2021 Nov; 27(Supplement_2):S25-S32. PubMed ID: 34791289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
    BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
    Sipponen T; Kärkkäinen P; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1221-9. PubMed ID: 18752630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
    Melmed GY; Dubinsky MC; Rubin DT; Fleisher M; Pasha SF; Sakuraba A; Tiongco F; Shafran I; Fernandez-Urien I; Rosa B; Papageorgiou NP; Leighton JA
    Gastrointest Endosc; 2018 Dec; 88(6):947-955.e2. PubMed ID: 30086261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Chen L; Zhong X; Li L; Li X; Liu Y; Guo C; Chen Y; Huang Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1360-1370. PubMed ID: 36631715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
    Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Faecal Calprotectin Level and Combined Endoscopic and Radiological Healing in Patients With Crohn's Disease Receiving Anti-tumour Necrosis Factor Therapy.
    Noh SM; Oh EH; Park SH; Lee JB; Kim JY; Park JC; Kim J; Ham NS; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Crohns Colitis; 2020 Sep; 14(9):1231-1240. PubMed ID: 32157278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S; Huang Z; Hou W; Lin Y; Yu J
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Capsule Endoscopy Crohn's Disease Activity Index, clinical activity and fecal calprotectin level in patients with isolated small intestine lesions].
    Timerbulatov MV; Grishina EE; Aitova LR; Senderovich EI; Ziganshin TM
    Khirurgiia (Mosk); 2021; (9):63-70. PubMed ID: 34480457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
    Volkers A; Bossuyt P; de Jong J; Pouillon L; Gecse K; Duijvestein M; Ponsioen C; D'Haens G; Löwenberg M
    Scand J Gastroenterol; 2022 Apr; 57(4):439-445. PubMed ID: 34968158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study.
    Wetwittayakhlang P; Verdon C; Starr M; Hahn GD; Golovics PA; Bessissow T; Afif W; Wild G; Bitton A; Lakatos PL
    Turk J Gastroenterol; 2023 Jun; 34(6):603-610. PubMed ID: 37162506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.